{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:11:28Z","timestamp":1772338288682,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Toxicol Adverse Drug Exp"],"published-print":{"date-parts":[[1989,12]]},"DOI":"10.1007\/bf03259923","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T11:37:39Z","timestamp":1354189059000},"page":"412-428","source":"Crossref","is-referenced-by-count":27,"title":["Poisoning Due to Class 1B Antiarrhythmic Drugs"],"prefix":"10.1007","volume":"4","author":[{"given":"Charles P.","family":"Denaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal L.","family":"Benowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259923_CR1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00005344-198311000-00027","volume":"5","author":"DR Abernethy","year":"1983","unstructured":"Abernethy DR, Greenblatt DJ. Impairment of lidocaine clearance in elderly male subjects. Journal of Cardiovascular Pharmacology 5: 1093\u20131096, 1983","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"BF03259923_CR2","first-page":"87","volume":"45","author":"J Adriani","year":"1966","unstructured":"Adriani J, Zepernick R, Hyde E. Influence of the status of the patient on systemic effects of local anesthetic agents. Anesthetics and Analgesia 45: 87\u201392, 1966","journal-title":"Anesthetics and Analgesia"},{"key":"BF03259923_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0196-0644(84)80015-3","volume":"13","author":"SN Alfano","year":"1984","unstructured":"Alfano SN, Leicht MJ, Skiendzielewski JJ. Lidocaine toxicity following subcutaneous administration. Annals of Emergency Medicine 13: 465\u2013467, 1984","journal-title":"Annals of Emergency Medicine"},{"key":"BF03259923_CR4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-107-5-693","volume":"107","author":"JB Arrowsmith","year":"1987","unstructured":"Arrowsmith JB, Creamer JI, Bosco L. Severe dermatologic reactions reported after treatment with tocainide. Annals of Internal Medicine 107: 693\u2013696, 1987","journal-title":"Annals of Internal Medicine"},{"key":"BF03259923_CR5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-8703(81)90115-0","volume":"102","author":"E Badui","year":"1981","unstructured":"Badui E, Garcia-Rubi D, Estanol B. Inadvertent massive lidocaine overdose causing temporary complete heart block in myocardial infarction. American Heart Journal 102: 801\u2013803, 1981","journal-title":"American Heart Journal"},{"key":"BF03259923_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2125.1982.tb01394.x","volume":"13","author":"A Barchowsky","year":"1982","unstructured":"Barchowsky A, Shand DG, Stargel WW, Wagner GS, Routledge PA. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction. British Journal of Clinical Pharmacology 13: 411\u2013415, 1982","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259923_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/096032718600500508","volume":"5","author":"J Barnfield","year":"1986","unstructured":"Barnfield J, Kemmenoe AV. A sudden death due to tocainide overdose. Human Toxicology 5: 337\u2013340, 1986","journal-title":"Human Toxicology"},{"key":"BF03259923_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/clpt.1982.56","volume":"31","author":"LA Bauer","year":"1982","unstructured":"Bauer LA, Brown T, Gibaldi M, Hudson L, Nelson S, et al. Influence of long-term infusions on lidocaine kinetics. Clinical Pharmacology and Therapeutics 31: 433\u2013437, 1982","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cpt1974161part187","volume":"16","author":"N Benowitz","year":"1974","unstructured":"Benowitz N, Forsyth RP, Melmon KL, Rowland M. Lidocaine disposition kinetics in monkey and man. 1. Prediction by a perfusion model. Clinical Pharmacology and Therapeutics 16: 87\u201398, 1974","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00003088-197601060-00001","volume":"1","author":"NL Benowitz","year":"1976","unstructured":"Benowitz NL, Meister W. Pharmacokinetics in patients with cardiac failure. Clinical Pharmacokinetics 1: 389\u2013405, 1976","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259923_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-197803030-00001","volume":"3","author":"NL Benowitz","year":"1978","unstructured":"Benowitz NL, Meister W. Clinical pharmacokinetics of lignocaine. Clinical Pharmacokinetics 3: 177\u2013201, 1978","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259923_CR12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0002-8703(84)90178-9","volume":"107","author":"T Bigger","year":"1984","unstructured":"Bigger T. The interaction of mexiletine with other cardiovascular drugs. American Heart Journal 107: 1079\u20131085, 1984","journal-title":"American Heart Journal"},{"key":"BF03259923_CR13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bmj.3.5667.390","volume":"3","author":"PF Binnion","year":"1969","unstructured":"Binnion PF, Murtagh G, Pollock AM, Fletcher E. Relation between plasma lignocaine levels and induced hemodynamic changes. British Medical Journal 3: 390\u2013392, 1969","journal-title":"British Medical Journal"},{"key":"BF03259923_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(25)29562-3","volume":"186","author":"J Blumer","year":"1973","unstructured":"Blumer J, Strong JM, Atkinson AJ. The convulsant potency of lidocaine and its N-dealkylated metabolites. Journal of Pharmacology and Experimental Therapeutics 186: 31\u201336, 1973","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259923_CR15","first-page":"677","volume":"2","author":"Boston Collaborative Drug Surveillance Program","year":"1972","unstructured":"Boston Collaborative Drug Surveillance Program. Drug-induced convulsions. Lancet 2: 677, 1972","journal-title":"Lancet"},{"key":"BF03259923_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM198701013160106","volume":"316","author":"RWF Campbell","year":"1987","unstructured":"Campbell RWF. Mexiletine. New England Journal of Medicine 316: 29\u201334, 1987","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jama.1973.03220070044011","volume":"223","author":"TO Cheng","year":"1973","unstructured":"Cheng TO, Wadhwa K. Sinus standstill following intravenous lidocaine administration. Journal of the American Medical Association 223: 790\u2013792, 1973","journal-title":"Journal of the American Medical Association"},{"key":"BF03259923_CR18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0002-8703(81)90114-9","volume":"102","author":"MSS Chow","year":"1981","unstructured":"Chow MSS, Ronfeldt RA, Ruffet D, Fieldman A. Lidocaine pharmacokinetics during cardiac arrest and external cardiopulmonary resuscitation. American Heart Journal 102: 799\u2013801, 1981","journal-title":"American Heart Journal"},{"key":"BF03259923_CR19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3565(25)33512-3","volume":"224","author":"MSS Chow","year":"1983","unstructured":"Chow MSS, Ronfeldt RA, Hamilton RA, Helmink R, Fieldman A. Effect of external cardiopulmonary resuscitation on lidocaine pharmacokinetics in dogs. Journal of Pharmacology and Experimental Therapeutics 224: 531\u2013537, 1983","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259923_CR20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/bmj.288.6419.760","volume":"288","author":"CWF Clarke","year":"1984","unstructured":"Clarke CWF, El-Mahdi EO. Fatal oral tocainide overdosage. British Medical Journal 288: 760, 1984","journal-title":"British Medical Journal"},{"key":"BF03259923_CR21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/0002-8703(80)90070-8","volume":"100","author":"G Cocco","year":"1980","unstructured":"Cocco G, Strozzi C, Chu D, Pansini R. Torsades de pointes as a manifestation of mexiletine toxicity. American Heart Journal 100: 878\u2013880, 1980","journal-title":"American Heart Journal"},{"key":"BF03259923_CR22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/000331978703800806","volume":"38","author":"A Cohen","year":"1987","unstructured":"Cohen A. Accidental overdose of tocainide successfully treated. Angiology 38: 614, 1987","journal-title":"Angiology"},{"key":"BF03259923_CR23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cpt197518159","volume":"18","author":"KA Collinsworth","year":"1975","unstructured":"Collinsworth KA, Strong JM, Atkinson Jr AJ, Winkie RA, Perlroth F, et al. Pharmacokinetics and metabolism of lidocaine in patients with renal failure. Clinical Pharmacology and Ther-apeutics 18: 59\u201364, 1975","journal-title":"Clinical Pharmacology and Ther-apeutics"},{"key":"BF03259923_CR24","first-page":"1","volume":"21","author":"BG Covino","year":"1987","unstructured":"Covino BG. Pharmacology of local anesthetic agents. Rational Drug Therapy 21: 1\u20139, 1987","journal-title":"Rational Drug Therapy"},{"key":"BF03259923_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0002-8703(82)90193-4","volume":"104","author":"R Davison","year":"1982","unstructured":"Davison R, Parker M, Atkinson AJ. Excessive serum lidocaine levels during maintenance infusions: Mechanisms and prevention. American Heart Journal 104: 203\u2013207, 1982","journal-title":"American Heart Journal"},{"key":"BF03259923_CR26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/01.RES.24.5.639","volume":"24","author":"LD Davis","year":"1969","unstructured":"Davis LD, Temte JV. Electrophysiological action of lidocaine on canine ventricular muscle and Purkinje fibres. Circulation Research 24: 639\u2013655, 1969","journal-title":"Circulation Research"},{"key":"BF03259923_CR27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/clpt.1983.122","volume":"34","author":"DE Drayer","year":"1983","unstructured":"Drayer DE, Lorenzo B, Werns S, Reidenberg MM. Plasma levels, protein binding and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Clinical Pharmacology and Therapeutics 34: 14\u201322, 1983","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/15563658608990445","volume":"24","author":"B Edgren","year":"1986","unstructured":"Edgren B, Tilelli J, Gehrz R. Intravenous lidocaine overdosage in a child. Clinical Toxicology 24: 51\u201358, 1986","journal-title":"Clinical Toxicology"},{"key":"BF03259923_CR29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/bmj.1.5342.1416-b","volume":"1","author":"JL Elder","year":"1964","unstructured":"Elder JL, Smith WG. Dangers of lignocaine. British Journal of Medicine 1: 1416\u20131417, 1964","journal-title":"British Journal of Medicine"},{"key":"BF03259923_CR30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0002-8703(81)90141-1","volume":"101","author":"RL Engler","year":"1981","unstructured":"Engler RL, Le Winter M. Tocainide-induced ventricular fibrillation. American Heart Journal 101: 494\u2013496, 1981","journal-title":"American Heart Journal"},{"key":"BF03259923_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-6576.1965.tb00522.x","volume":"16","author":"S Englesson","year":"1965","unstructured":"Englesson S, Paymaster NJ, Hill TR. Electrical seizure activity produced by xylocaine and citanest. Acta Anacsthesiologica Scandinavica 16: 47\u201350, 1965","journal-title":"Acta Anacsthesiologica Scandinavica"},{"key":"BF03259923_CR32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-100-1-162_1","volume":"100","author":"GP Fasola","year":"1984","unstructured":"Fasola GP, D\u2019Osualdo F, de Panghcr V, Barducci E. Thrombocytopenia and mexiletine. Annals of Internal Medicine 100: 162, 1984","journal-title":"Annals of Internal Medicine"},{"key":"BF03259923_CR33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/clpt.1983.249","volume":"34","author":"PE Fenster","year":"1983","unstructured":"Fenster PE, Kern KB. Mexiletine in refractory ventricular arrhythmias. Clinical Pharmacology and Therapeutics 34: 777\u2013784, 1983","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJM197907053010121","volume":"301","author":"F Finkelstein","year":"1979","unstructured":"Finkelstein F, Kreeft J. Massive lidocaine poisoning. New England Journal of Medicine 301: 50, 1979","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003088-198308010-00004","volume":"8","author":"F Follath","year":"1983","unstructured":"Follath F, Ganzinger U, Schuetz E. Reliability of antiarrhythmic drug plasma concentration monitoring. Clinical Pharmacokinetics 8: 63\u201382, 1983","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259923_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00542457","volume":"22","author":"MD Freedman","year":"1982","unstructured":"Freedman MD, Gal J, Freed CR. Extracorporeal pump assistance \u2014novel treatment for acute lidocaine poisoning. European Journal of Clinical Pharmacology 22: 129\u2013135, 1982","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259923_CR37","first-page":"426","volume":"306","author":"RJ Fruncillo","year":"1982","unstructured":"Fruncillo RJ, Gibbons W, Bowman SM. CNS toxicity after ingestion of topical lidocaine. New England Journal of Medicine 306: 426\u2013427, 1982","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.CIR.46.3.498","volume":"46","author":"OW Gamble","year":"1972","unstructured":"Gamble OW, Cohn K. Effect of propranolol, procainamide and lidocaine in ventricular automaticity and reentry in experimental myocardial infarction. Circulation 46: 498\u2013506, 1972","journal-title":"Circulation"},{"key":"BF03259923_CR39","first-page":"964","volume":"7","author":"JS Geddes","year":"1972","unstructured":"Geddes JS, Webb S, Pantridge JF. Limitation of lignocaine in control of early ventricular dysrhythmias complicating acute myocardial infarction. British Heart Journal 7: 964\u2013965, 1972","journal-title":"British Heart Journal"},{"key":"BF03259923_CR40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(72)90066-5","volume":"30","author":"G Gerstenblith","year":"1972","unstructured":"Gerstenblith G, Spear JF, Moore EN. Quantitative study of the effect of lidocaine on the threshold for ventricular fibrillation in the dog. American Journal of Cardiology 30: 242\u2013247, 1972","journal-title":"American Journal of Cardiology"},{"key":"BF03259923_CR41","first-page":"1301","volume":"304","author":"CF Graham","year":"1980","unstructured":"Graham CF, Turner WM, Jones JK. Lidocaine-propranolol interactions. New England Journal of Medicine 304: 1301, 1980","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/clpt.1980.10","volume":"27","author":"C Graffner","year":"1980","unstructured":"Graffner C, Conradson TB, Hofvendahl S, Ryden L. Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction. Clinical Pharmacology and Therapeutics 27: 64\u201371, 1980","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2125.1986.tb02829.x","volume":"21","author":"O Grech Belanger","year":"1986","unstructured":"Grech Belanger O, Turgeon J, Gilbert M. Stereoselective disposition of mexiletine in man. British Journal of Clinical Pharmacology 21: 481\u2013487, 1986","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259923_CR44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archotol.1985.00800070050005","volume":"111","author":"DJ Greenblatt","year":"1985","unstructured":"Greenblatt DJ, Benjamin DM, Willis CR, Harmatz JS, Zinny MA. Lidocaine plasma concentrations following administration of intraoral lidocaine solution. Archives of Otolaryngology 111: 298\u2013300, 1985","journal-title":"Archives of Otolaryngology"},{"key":"BF03259923_CR45","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM197612162952503","volume":"295","author":"DA Grimes","year":"1976","unstructured":"Grimes DA, Cates W. Deaths from paracervical anesthesia used for first trimester abortion. New England Journal of Medicine 295: 1397\u20131399, 1976","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9149(74)90606-7","volume":"33","author":"PK Gupta","year":"1974","unstructured":"Gupta PK, Lichstein E, Chadda KD. Lidocaine-induced heart block in patients with bundle branch block. American Journal of Cardiology 33: 487\u2013492, 1974","journal-title":"American Journal of Cardiology"},{"key":"BF03259923_CR47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/cpt1975176669","volume":"17","author":"H Halkin","year":"1975","unstructured":"Halkin H, Meffin P, Melmon KL, Rowland M. Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite. Clinical Pharmacology and Therapeutics 17: 669\u2013676, 1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0196-0644(88)80623-1","volume":"17","author":"GP Hess","year":"1988","unstructured":"Hess GP, Walson PD. Seizures secondary to oral viscous lidocaine. Annals of Emergency Medicine 17: 725\u2013727, 1988","journal-title":"Annals of Emergency Medicine"},{"key":"BF03259923_CR49","first-page":"344","volume":"316","author":"GI Holmes","year":"1987","unstructured":"Holmes GI, Shapiro DA, Nicolodi LK, Irvin JD. Letter to the editor. New England Journal of Medicine 316: 344, 1987","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0002-8703(80)90210-0","volume":"100","author":"HR Horn","year":"1980","unstructured":"Horn HR, Hadidian Z, Johnson JL, Vassallo HG, Williams JH, et al. Safety evaluation of tocainide in the American Emergency Use Program. American Heart Journal 100: 1037\u20131040, 1980","journal-title":"American Heart Journal"},{"key":"BF03259923_CR51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1378\/chest.81.5.644","volume":"81","author":"JJ Howard","year":"1982","unstructured":"Howard JJ, Mohsenifar Z, Simons SM. Adult respiratory distress syndrome following administration of lidocaine. Chest 81: 644\u2013645, 1982","journal-title":"Chest"},{"key":"BF03259923_CR52","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/0002-8703(80)90216-1","volume":"100","author":"H Ikram","year":"1980","unstructured":"Ikram H. Hemodynamic and electrophysiological interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide. American Heart Journal 100: 1076\u20131080, 1980","journal-title":"American Heart Journal"},{"key":"BF03259923_CR53","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/clpt.1985.86","volume":"37","author":"JE Jackson","year":"1985","unstructured":"Jackson JE, Bentley JB, Glass SJ, Fukui T, Gandolfi AJ, et al. Effects of hislaminc-2 receptor blockade on lidocaine kinetics. Clinical Pharmacology and Therapeutics 37: 544\u2013548, 1985","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(76)90272-5","volume":"1","author":"P Jequier","year":"1976","unstructured":"Jequier P, Jones R, Mackintosh A. Fatal mcxiletine overdose. Lancet 1: 429, 1976","journal-title":"Lancet"},{"key":"BF03259923_CR55","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(68)90120-7","volume":"1","author":"DE Jewitt","year":"1968","unstructured":"Jewitt DE, Kishon Y, Thomas M. Lignocaine in the management of arrhythmias after acute myocardial infarction. Lancet 1: 266\u2013270, 1968","journal-title":"Lancet"},{"key":"BF03259923_CR56","first-page":"522","volume":"14","author":"FF Kao","year":"1959","unstructured":"Kao FF, Jalar UH. The central action of lignocaine and its effect on cardiac output. British Journal of Pharmacology 14: 522\u2013526, 1959","journal-title":"British Journal of Pharmacology"},{"key":"BF03259923_CR57","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00000542-198611000-00036","volume":"65","author":"PM Kempen","year":"1986","unstructured":"Kempen PM. Lethal\/toxic injection of 20% lidocainc: a well-known complication of an unnecessary preparation? Anesthesiology 65: 564\u2013565, 1986","journal-title":"Anesthesiology"},{"key":"BF03259923_CR58","first-page":"643","volume":"64","author":"WY Kim","year":"1979","unstructured":"Kim WY, Pomcrance JJ, Miller AA. Lidocaine intoxication in a newborn following local anesthesia for episiotomy. Pediatrics 64: 643\u2013645, 1979","journal-title":"Pediatrics"},{"key":"BF03259923_CR59","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1378\/chest.77.6.726","volume":"77","author":"MD Klein","year":"1980","unstructured":"Klein MD, Levine PA, Ryan TJ. Antiarrhythmic efficacy, pharmacokinetics and clinical safety of tocainide in convalescent myocardial infarction patients. Chest 77: 726\u2013730, 1980","journal-title":"Chest"},{"key":"BF03259923_CR60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.RES.36.1.84","volume":"36","author":"J Kupersmith","year":"1976","unstructured":"Kupersmith J, Antman EM, Hoffman BF. In vivo electrophysiological effects of lidocainc in canine acute myocardial infarction. Circulation Research 36: 84\u201391, 1976","journal-title":"Circulation Research"},{"key":"BF03259923_CR61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01061847","volume":"11","author":"MS Lennard","year":"1983","unstructured":"Lennard MS, Tucker GT, Woods HF. Time-dependent kinetics of lignocaine in the isolated perfused rat liver. Journal of Pharmacokinetics and Biopharmaceutics 11: 165\u2013182, 1983","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"BF03259923_CR62","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7326\/0003-4819-87-6-700","volume":"87","author":"J LeLorier","year":"1977","unstructured":"LeLorier J, Grenon D, Latour Y, Caille G, Dumont G, et al. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Annals of Internal Medicine 87: 700\u2013702, 1977a","journal-title":"Annals of Internal Medicine"},{"key":"BF03259923_CR63","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-3565(25)31077-3","volume":"203","author":"J LeLorier","year":"1977","unstructured":"LeLorier J, Moisan R, Gagne J, Caille G. Effect of the duration of infusion on the disposition of lidocaine in dogs. Journal of Pharmacology and Experimental Therapeutics 203: 507\u2013511, 1977b","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259923_CR64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9149(73)91042-4","volume":"31","author":"E Lichstein","year":"1973","unstructured":"Lichstein E, Chadda KD, Gupta PK. Atrioventricular block with lidocaine therapy. American Journal of Cardiology 31: 277\u2013281, 1973","journal-title":"American Journal of Cardiology"},{"key":"BF03259923_CR65","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJM197412192912504","volume":"291","author":"KI Lie","year":"1974","unstructured":"Lie KI, Welleng HJ, van Capelle FJ, Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. New England Journal of Medicine 291: 1324\u20131326, 1974","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0002-8703(63)90008-5","volume":"65","author":"RJ Luchi","year":"1963","unstructured":"Luchi RJ, Helwig J, Conn HL. Quinidine toxicity and its treatment. An experimental study. American Heart Journal 65: 340\u2013348, 1963","journal-title":"An experimental study. American Heart Journal"},{"key":"BF03259923_CR67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2125.1983.tb02162.x","volume":"16","author":"BG Mitchell","year":"1983","unstructured":"Mitchell BG, Clements JA, Pottage A, Prescott LF. Mexiletine disposition. British Journal of Clinical Pharmacology 16: 281\u2013284, 1983","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259923_CR68","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/bja\/56.12.1439","volume":"56","author":"J Noble","year":"1984","unstructured":"Noble J, Kennedy DJ, Latimer RD, Hardy I, Bethune DW, et al. Massive lignocainc overdose during cardiopulmonary bypass: successful treatment with cardiac pacing. British Journal of Anaesthesia 56: 1439\u20131441, 1984","journal-title":"British Journal of Anaesthesia"},{"key":"BF03259923_CR69","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/archinte.1980.00330220067023","volume":"140","author":"WJ O\u2019Donohue","year":"1980","unstructured":"O\u2019Donohue WJ, Moss LM, Angelillo VA. Acute methemoglobinemia induced by topical benzocaine and lidocaine. Archives of Internal Medicine 140: 1508\u20131509, 1980","journal-title":"Archives of Internal Medicine"},{"key":"BF03259923_CR70","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1520\/JFS11045J","volume":"30","author":"MA Peat","year":"1985","unstructured":"Peat MA, Deyman ME, Crouch DJ, Margot P, Finkle BS. Concentrations of lidocainc and monoethylglycylxylididc (MEGX) in lidocaine associated deaths. Journal of Forensic Sciences 30: 1048\u20131057, 1985","journal-title":"Journal of Forensic Sciences"},{"key":"BF03259923_CR71","first-page":"695","volume":"38","author":"C Pernot","year":"1983","unstructured":"Pernot C, Marcon F, Weber JL, Netter P, Trechot P. Effets indesirables hepatiques de la mexiletine: \u00e0 propos de 6 observation. Therapie 38: 695\u2013700, 1983","journal-title":"Therapie"},{"key":"BF03259923_CR72","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/BF00542518","volume":"25","author":"PJ Pentikainen","year":"1983","unstructured":"Pentikainen PJ, Halinen MO, Helin MJ. Pharmacokinctics of oral mexiletine in patients with acute myocardial infarction. European Journal of Clinical Pharmacology 25: 773\u2013777, 1983","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259923_CR73","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-8703(76)80252-9","volume":"92","author":"HJ Pfeifer","year":"1976","unstructured":"Pfeifer HJ, Greenblatt DJ, Koch-Weser J. Clinical use and toxicity of intravenous lidocaine: a report from the Boston Collaborative Drug Surveillance Program. American Heart Journal 92: 168\u2013173, 1976","journal-title":"American Heart Journal"},{"key":"BF03259923_CR74","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0002-9149(81)90191-0","volume":"47","author":"PJ Podrid","year":"1981","unstructured":"Podrid PJ, Lown B. Mexiletine for ventricular arrhythmias. American Journal of Cardiology 47: 895\u2013902, 1981","journal-title":"American Journal of Cardiology"},{"key":"BF03259923_CR75","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1520\/JFS11794J","volume":"29","author":"A Poklis","year":"1984","unstructured":"Poklis A, Mackell MA, Tucker EF. Tissue distribution of lidocaine after fatal accidental injection. Journal of Forensic Sciences 29: 1229\u20131236, 1984","journal-title":"Journal of Forensic Sciences"},{"key":"BF03259923_CR76","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/bmj.1.6015.939","volume":"1","author":"F Prescott","year":"1976","unstructured":"Prescott F, Adjepon-Yamoah KK, Talbot RG. Impaired lignocaine metabolism in patients with myocardial infarction and cardiac failure. British Medical Journal 1: 939\u2013941, 1976","journal-title":"British Medical Journal"},{"key":"BF03259923_CR77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/clpt.1986.141","volume":"40","author":"AW Rademaker","year":"1986","unstructured":"Rademaker AW, Kellen J, Tarn YK, Wyse DG. Character of adverse effects of prophylactic lidocaine in the coronary care unit. Clinical Pharmacology and Therapeutics 40: 71\u201380, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR78","first-page":"302","volume-title":"Pharmacological Basis of Therapeutics","author":"JM Ritchie","year":"1985","unstructured":"Ritchie JM, Green NM. Local anesthetics. In Goodman et al. (Eds) Pharmacological Basis of Therapeutics, 7th ed., pp. 302\u2013321, Macmillan, New York, 1985","edition":"7"},{"issue":"A","key":"BF03259923_CR79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurheartj\/8.suppl_A.21","volume":"8","author":"P Rizzon","year":"1987","unstructured":"Rizzon P, Di Biase M, Favale S, Visani L. Class 1B agents lidocaine, mexiletine, tocainide, phenytoin. European Heart Journal 8 (Suppl. A): 21\u201325, 1987","journal-title":"European Heart Journal"},{"key":"BF03259923_CR80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM198607033150107","volume":"315","author":"DM Roden","year":"1986","unstructured":"Roden DM, Woosley RL. Tocainide. New England Journal of Medicine 315: 41\u201345, 1986","journal-title":"New England Journal of Medicine"},{"key":"BF03259923_CR81","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/hrt.38.12.1262","volume":"38","author":"JC Roos","year":"1976","unstructured":"Roos JC, Paalman ACA, Dunning AJ. Electrophysiological effects of mexiletine in man. British Heart Journal 38: 1262\u20131271, 1976","journal-title":"British Heart Journal"},{"key":"BF03259923_CR82","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/0003-4819-93-5-701","volume":"93","author":"PA Routledge","year":"1980","unstructured":"Routledge PA, Stargel WW, Wagner GS, Shand DG. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Annals of Internal Medicine 93: 701\u2013704, 1980","journal-title":"Annals of Internal Medicine"},{"key":"BF03259923_CR83","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9149(79)80017-X","volume":"43","author":"W Ryan","year":"1979","unstructured":"Ryan W, Engler R, LeWinter M, Karliner JS. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias. American Journal of Cardiology 43: 285\u2013300, 1979","journal-title":"American Journal of Cardiology"},{"key":"BF03259923_CR84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1176\/ajp.144.12.1623-a","volume":"144","author":"SM Saravay","year":"1987","unstructured":"Saravay SM, Marke J, Steinberg MD, Rabiner CJ. Doom anxiety and delirium in lidocaine toxicity. American Journal of Psychiatry 144: 159\u2013163, 1987","journal-title":"American Journal of Psychiatry"},{"key":"BF03259923_CR85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archinte.1981.00340010039011","volume":"141","author":"DR Sawyer","year":"1981","unstructured":"Sawyer DR, Ludden TM, Crawford MH. Continuous infusion of lignocaine in patients with cardiac arrhythmias: unpredictability of plasma concentrations. Archives of Internal Medicine 141: 43\u201345, 1981","journal-title":"Archives of Internal Medicine"},{"key":"BF03259923_CR86","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/106002808602000401","volume":"20","author":"BJ Schrader","year":"1986","unstructured":"Schrader BJ, Bauman JL. Mexiletine: a new type I antiarrhythmic agent. Drug Intelligence and Clinical Pharmacy 20: 255\u2013260, 1986","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259923_CR87","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0196-0644(87)80567-X","volume":"16","author":"MR Schuster","year":"1987","unstructured":"Schuster MR, Paris PM, Kaplan RM, Stewart RD. Effect on the seizure threshold in dogs of tocainide\/lidocaine administration. Annals of Emergency Medicine 16: 749\u2013751, 1987","journal-title":"Annals of Emergency Medicine"},{"key":"BF03259923_CR88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2125.1984.tb05012.x","volume":"17","author":"AJ Sedman","year":"1984","unstructured":"Sedman AJ, Gal J, Mastropaolo W, Johnson P, Maloney JD, et al. Serum tocainide enantiomer concentrations in human subjects. British Journal of Clinical Pharmacology 17: 113\u2013115, 1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259923_CR89","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1520\/JFS11193J","volume":"32","author":"K Sperry","year":"1987","unstructured":"Sperry K, Wohlenberg N, Standefer KC. Fatal intoxication by tocainide. Journal of Forensic Sciences 32: 1440\u20131446, 1987","journal-title":"Journal of Forensic Sciences"},{"key":"BF03259923_CR90","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/00220345810600080904","volume":"60","author":"GR Strichartz","year":"1981","unstructured":"Strichartz GR. Current concepts of the mechanism of action of local anesthetics. Journal of Dental Research 60: 1460\u20131467, 1981","journal-title":"Journal of Dental Research"},{"key":"BF03259923_CR91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cpt197314167","volume":"14","author":"JM Strong","year":"1973","unstructured":"Strong JM, Parker M, Atkinson AJ. Identification of glycinexylidide in patients treated with intravenous lidocaine. Clinical Pharmacology and Therapeutics 14: 67\u201372, 1973","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR92","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/cpt1975172184","volume":"17","author":"JM Strong","year":"1975","unstructured":"Strong JM, Mayfield DE, Atkinson AJ, Burris BC, Raymon F, et al. Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide. Clinical Pharmacology and Therapeutics 17: 184\u2013194, 1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259923_CR93","doi-asserted-by":"crossref","first-page":"223S","DOI":"10.1111\/j.1365-2125.1982.tb01915.x","volume":"13","author":"TL Svendsen","year":"1982","unstructured":"Svendsen TL, Tango M, Waldorff S, Steiness E, Trap-Jensen J. Effects of propranolol and pindolol on plasma lignocaine clearance in man. British Journal of Clinical Pharmacology 13: 223S\u2013226S, 1982","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259923_CR94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00007691-198709000-00006","volume":"9","author":"AH Thomson","year":"1987","unstructured":"Thomson AH, Kelman AW, de Vane PJ, Stewart Hillis W, Whiting B. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias. Therapeutic Drug Monitoring 9: 283\u2013291, 1987a","journal-title":"Therapeutic Drug Monitoring"},{"key":"BF03259923_CR95","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01062338","volume":"15","author":"AH Thomson","year":"1987","unstructured":"Thomson AH, Elliott HL, Kelman AW, Meredith PA, Whiting B. The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects. Journal of Pharmacokinetics and Biopharmaceutics 15: 101\u2013115, 1987b","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"BF03259923_CR96","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0002-8703(71)90308-5","volume":"82","author":"PD Thomson","year":"1971","unstructured":"Thomson PD, Rowland M, Melmon KL. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. American Heart Journal 82: 417\u2013421, 1971","journal-title":"American Heart Journal"},{"key":"BF03259923_CR97","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00605996","volume":"23","author":"S Vozeh","year":"1982","unstructured":"Vozeh S, Katz G, Steiner V, Follath F. Population pharmacokinetic parameters in patients treated with oral mexiletine. European Journal of Clinical Pharmacology 23: 445\u2013451, 1982","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259923_CR98","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2165\/00003088-198409040-00005","volume":"9","author":"S Vozeh","year":"1984","unstructured":"Vozeh S, Berger M, Wenk M, Ritz R, Follath F. Rapid prediction of individual dosage requirements for lignocaine. Clinical Pharmacokinetics 9: 354\u2013363, 1984","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259923_CR99","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0002-8703(87)90053-6","volume":"113","author":"S Vozeh","year":"1987","unstructured":"Vozeh S, Uematsu T, Ritz R, Schmidlin O, Kaufman G, et al. Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performance. American Heart Journal 113: 928\u2013933, 1987","journal-title":"American Heart Journal"},{"key":"BF03259923_CR100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00609893","volume":"24","author":"U Wiegers","year":"1983","unstructured":"Wiegers U, Hanrath P, Kuck KH, Pottage A, Graffner C, et al. Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis. European Journal of Clinical Pharmacology 24: 503\u2013507, 1983","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259923_CR101","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00000542-195711000-00002","volume":"18","author":"LA Woods","year":"1957","unstructured":"Woods LA, Haggart J. Apneic and hypotensive effects of local anesthetic drugs in dogs and mice under general anesthesia. Anesthesiology 18: 831\u2013840, 1957","journal-title":"Anesthesiology"},{"key":"BF03259923_CR102","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0002-8703(77)80471-7","volume":"94","author":"RA Zito","year":"1977","unstructured":"Zito RA, Reid PR, Longstretch JA. Variability of early lignocaine levels in patients. American Heart Journal 94: 292\u2013296, 1977","journal-title":"American Heart Journal"}],"container-title":["Medical Toxicology and Adverse Drug Experience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259923\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T23:10:51Z","timestamp":1745363451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259923"}},"subtitle":["Lignocaine, Mexiletine and Tocainide"],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["BF03259923"],"URL":"https:\/\/doi.org\/10.1007\/bf03259923","relation":{},"ISSN":["0113-5244","1179-1942"],"issn-type":[{"value":"0113-5244","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,12]]}}}